These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32512213)

  • 1. Cut-off values for Gaussian first-trimester screening for early-onset preeclampsia with maternal history, biochemical markers and uterine artery Doppler.
    Mendoza M; Tur H; Garcia-Manau P; Hurtado I; Serrano B; Lopez-Martinez RM; Castellote L; Martinez L; Bonacina E; Carreras E
    J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101827. PubMed ID: 32512213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of first-trimester combined screening for early-onset and preterm pre-eclampsia at 8-10 compared with 11-13 weeks' gestation.
    Mendoza M; Garcia-Manau P; Arévalo S; Avilés M; Serrano B; Sánchez-Durán MÁ; Garcia-Ruiz I; Bonacina E; Carreras E
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):84-90. PubMed ID: 32388877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
    Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new model for screening for early-onset preeclampsia.
    Serra B; Mendoza M; Scazzocchio E; Meler E; Nolla M; Sabrià E; Rodríguez I; Carreras E
    Am J Obstet Gynecol; 2020 Jun; 222(6):608.e1-608.e18. PubMed ID: 31972161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume.
    Sonek J; Krantz D; Carmichael J; Downing C; Jessup K; Haidar Z; Ho S; Hallahan T; Kliman HJ; McKenna D
    Am J Obstet Gynecol; 2018 Jan; 218(1):126.e1-126.e13. PubMed ID: 29097177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation.
    O'Gorman N; Wright D; Syngelaki A; Akolekar R; Wright A; Poon LC; Nicolaides KH
    Am J Obstet Gynecol; 2016 Jan; 214(1):103.e1-103.e12. PubMed ID: 26297382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women.
    Audibert F; Boucoiran I; An N; Aleksandrov N; Delvin E; Bujold E; Rey E
    Am J Obstet Gynecol; 2010 Oct; 203(4):383.e1-8. PubMed ID: 20691410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation.
    Tan MY; Syngelaki A; Poon LC; Rolnik DL; O'Gorman N; Delgado JL; Akolekar R; Konstantinidou L; Tsavdaridou M; Galeva S; Ajdacka U; Molina FS; Persico N; Jani JC; Plasencia W; Greco E; Papaioannou G; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Aug; 52(2):186-195. PubMed ID: 29896812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competing-risks model in screening for pre-eclampsia in twin pregnancy according to maternal factors and biomarkers at 11-13 weeks' gestation.
    Francisco C; Wright D; Benkő Z; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Nov; 50(5):589-595. PubMed ID: 28556556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for preeclampsia in low-risk twin pregnancies at early gestation.
    Chen J; Zhao D; Liu Y; Zhou J; Zou G; Zhang Y; Guo M; Duan T; Van Mieghem T; Sun L
    Acta Obstet Gynecol Scand; 2020 Oct; 99(10):1346-1353. PubMed ID: 32356359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First trimester maternal serum analytes and second trimester uterine artery Doppler in the prediction of preeclampsia and fetal growth restriction.
    Yu N; Cui H; Chen X; Chang Y
    Taiwan J Obstet Gynecol; 2017 Jun; 56(3):358-361. PubMed ID: 28600048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation.
    Gallo DM; Wright D; Casanova C; Campanero M; Nicolaides KH
    Am J Obstet Gynecol; 2016 May; 214(5):619.e1-619.e17. PubMed ID: 26627730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficiency of first-trimester uterine artery Doppler, a-disintegrin and metalloprotease 12, pregnancy-associated plasma protein a, and maternal characteristics in the prediction of preeclampsia.
    Goetzinger KR; Zhong Y; Cahill AG; Odibo L; Macones GA; Odibo AO
    J Ultrasound Med; 2013 Sep; 32(9):1593-600. PubMed ID: 23980220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia.
    Di Lorenzo G; Ceccarello M; Cecotti V; Ronfani L; Monasta L; Vecchi Brumatti L; Montico M; D'Ottavio G
    Placenta; 2012 Jun; 33(6):495-501. PubMed ID: 22459245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of the Gaussian first-trimester combined screening for pre-eclampsia to predict small-for-gestational-age neonates.
    Mendoza M; Serrano B; Bonacina E; Capote S; Garcia-Manau P; Regincós L; Murcia MT; Barberan L; Míguez M; Carreras E
    Int J Gynaecol Obstet; 2022 Feb; 156(2):322-330. PubMed ID: 33724448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-trimester screening for pre-eclampsia and small for gestational age: A comparison of the gaussian and Fetal Medicine Foundation algorithms.
    Serrano B; Bonacina E; Rodo C; Garcia-Manau P; Sanchez-Duran MÁ; Pancorbo M; Forcada C; Murcia MT; Perestelo A; Armengol-Alsina M; Mendoza M; Carreras E
    Int J Gynaecol Obstet; 2023 Jan; 160(1):150-160. PubMed ID: 35695395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASPRE trial: performance of screening for preterm pre-eclampsia.
    Rolnik DL; Wright D; Poon LCY; Syngelaki A; O'Gorman N; de Paco Matallana C; Akolekar R; Cicero S; Janga D; Singh M; Molina FS; Persico N; Jani JC; Plasencia W; Papaioannou G; Tenenbaum-Gavish K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Oct; 50(4):492-495. PubMed ID: 28741785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective Validation of First-Trimester Screening for Preterm Preeclampsia in Nulliparous Women (PREDICTION Study).
    Guerby P; Audibert F; Johnson JA; Okun N; Giguère Y; Forest JC; Chaillet N; Mâsse B; Wright D; Ghesquiere L; Bujold E
    Hypertension; 2024 Jul; 81(7):1574-1582. PubMed ID: 38708601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-trimester 3-dimensional power Doppler placental vascularization indices from the whole placenta versus the placental bed to predict preeclampsia: does pregnancy-associated plasma protein a or uterine artery Doppler sonography help?
    Hannaford KE; Tuuli M; Goetzinger KR; Odibo L; Cahill AG; Macones G; Odibo AO
    J Ultrasound Med; 2015 Jun; 34(6):965-70. PubMed ID: 26014314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of screening for hypertensive disorders of pregnancy at 11-13 weeks in a Scandinavian population.
    Skråstad RB; Hov GG; Blaas HG; Romundstad PR; Salvesen KÅ
    Acta Obstet Gynecol Scand; 2014 Dec; 93(12):1238-47. PubMed ID: 25146367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.